azacitidine oral,alemtuzumab
sanofi
['lymphoma', 'aza ', 'alemtuzumab', 'lymsm', 't-cell lymphoma', 'cml']
fascinating to see efficacy of x+chop paradigms in the t-cell lymphoma space. dr. zinzani calls attention to both aza and alemtuzumab combinations with high response rates. #lymsm #17icml cc 
Lymphoma doc & patient-reported outcomes researcher in #lymsm and #mmsm @CUHematology. Founder of https://t.co/kN6qeGFEox, @inTrainingDoc & @inHouseMag. 🏳️‍🌈